Thyroiditis and Hair loss
Summary:
Hair loss is found among people with Thyroiditis, especially for people who are female, 60+ old.
The study analyzes which people have Hair loss with Thyroiditis. It is created by eHealthMe based on reports of 21 people who have Thyroiditis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Thyroiditis?
Thyroiditis (inflammation of thyroid gland) is found to be associated with 306 drugs and 394 conditions by eHealthMe. Check the latest studies of Thyroiditis.
What is Hair loss?
Hair loss is found to be associated with 2,411 drugs and 3,517 conditions by eHealthMe. Check the latest studies of Hair loss.
21 people who have Thyroiditis and Hair Loss are studied.

Gender of people who have Thyroiditis and experienced Hair Loss *:
- female: 95.24 %
- male: 4.76 %
Age of people who have Thyroiditis and experienced Hair Loss *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 25 %
- 40-49: 25 %
- 50-59: 25 %
- 60+: 25 %
Common co-existing conditions for these people *:
- Rickets (softening of bones): 1 person, 4.76%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.76%
- Pain: 1 person, 4.76%
- Nervousness: 1 person, 4.76%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.76%
- Hypersensitivity: 1 person, 4.76%
- Headache (pain in head): 1 person, 4.76%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.76%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 4.76%
- Depression: 1 person, 4.76%
Common drugs taken by these people *:
- Novothyrox: 12 people, 57.14%
- Euthyrox: 3 people, 14.29%
- Vitamin D: 1 person, 4.76%
- Tolterodine: 1 person, 4.76%
- Synthroid: 1 person, 4.76%
- Remicade: 1 person, 4.76%
- Omeprazole: 1 person, 4.76%
- Nasonex: 1 person, 4.76%
- Effexor: 1 person, 4.76%
- Clonazepam: 1 person, 4.76%
Common symptoms for these people *:
- Dizziness: 11 people, 52.38%
- Weakness: 10 people, 47.62%
- Headache (pain in head): 10 people, 47.62%
- Fatigue (feeling of tiredness): 10 people, 47.62%
- Joint Pain: 7 people, 33.33%
- Irritability: 6 people, 28.57%
- Muscle Aches (muscle pain): 6 people, 28.57%
- Insomnia (sleeplessness): 6 people, 28.57%
- Disturbance In Attention: 5 people, 23.81%
- Muscle Spasms (muscle contraction): 5 people, 23.81%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Hair loss?
- Check whether Hair loss is associated with a drug or a conditionRelated publications that referenced our studies
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Thyroiditis (4,158 reports)
- Hair loss (271,201 reports)
All the drugs that are associated with Hair loss:
- Hair loss (2,411 drugs)
All the conditions that are associated with Hair loss:
- Hair loss (3,517 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Hair loss and Thyroiditis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Quetiapine Fumarate cause Haematocrit Decreased? - 4 seconds ago
- Could Floxin cause Abdominal Distension? - 12 seconds ago
- Prozac vs. Adderall Xr 10, side effect and effectiveness comparison - 12 seconds ago
- Gastroesophageal Reflux Disease and Exposure To Communicable Disease - 13 seconds ago
- Pantoprazole and Gastroesophageal Reflux Disease for Women aged 60+ - 14 seconds ago
- Pantoprazole and Gastro-Oesophageal Reflux Disease for Women aged 60+ - 15 seconds ago
- Pantoprazole and Reflux for Women aged 60+ - 15 seconds ago
- Pantoprazole and Heartburn for Women aged 60+ - 15 seconds ago
- Pantoprazole and Non-Cardiac Chest Pain for Women aged 60+ - 15 seconds ago
- Pantoprazole and Gerds for Women aged 60+ - 16 seconds ago